ArticleKidney research and clinical practice2024
Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future.
Article in Kidney research and clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and risk factors of falls in people on hemodialysis: a systematic review and meta-analysis.Renal failure · 2025Pooled it
- Association between ultrafiltration variability and clinical outcomes in patients undergoing hemodialysis.Renal failure · 2026Article
- K-SALT Equation for Urinary Sodium Estimation in CKD.Kidney international reports · 2026Article
- Lived Experiences of Women with Arteriovenous Fistula Undergoing Hemodialysis: A Phenomenological Study.Healthcare (Basel, Switzerland) · 2026Article
- Disease Burden and Disparities of Care for Kidney Health in the Asian Pacific Region: Summary Report From the Diversity and Equity Committee of APSN.Nephrology (Carlton, Vic.) · 2026Review
- The Proposed Chronic Kidney Disease Management Act in Korea: A Step Toward a National Strategy for Kidney Disease Prevention and Care.Electrolyte & blood pressure : E & BP · 2026Article
- Characteristics of peritoneal dialysis-related infection according to pet ownership: An 8-year single-center experience.PloS one · 2026Article
- Shared decision-making for kidney replacement therapy: a comprehensive review and a proposed model.The Korean journal of internal medicine · 2025Review
- Analysis of Self-Sufficiency and Factors Affecting Migration Between Medical Service Regions in Korea Among CKD Patients.Journal of Korean medical science · 2025Article
- Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study.Diabetes & metabolism journal · 2025Article
- Long-term use of proton pump inhibitors was associated with rapid progression to end stage kidney disease in a Korean nationwide study.Scientific reports · 2024Article
- Management Strategies for Potassium Levels During Non-steroidal Mineralocorticoid Receptor Antagonist Therapy: A Comprehensive Review.Electrolyte & blood pressure : E & BP · 2024Review
- Obesity and chronic kidney disease, an important piece in the puzzle of Cardiovascular-Kidney- Metabolic syndrome.The Korean journal of internal medicine · 2024Article
- Comparative Analysis of Seven Equations for Estimated Glomerular Filtration Rate and Their Impact on Chronic Kidney Disease Categorization in Korean Patients at Local Clinics and Hospitals.Journal of clinical medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In response to the increase in the prevalence of chronic kidney disease (CKD) in Korea, the growth of patients requiring renal replacement therapy and the subsequent increase in medical costs, the rapid expansion of patients with end-stage kidney disease (ESKD), and the decrease in patients receiving home therapy, including peritoneal dialysis, the Korean Society of Nephrology has proclaimed the new policy, Kidney Health Plan 2033 (KHP 2033). KHP 2033 would serve as a milestone to bridge the current issues to a future solution by directing the prevention and progression of CKD and ESKD, particularly diabetic kidney disease, and increasing the proportion of home therapy, thereby reducing the socioeconomic burden of kidney disease and improving the quality of life. Here, we provide the background for the necessity of KHP 2033, as well as the contents of KHP 2033, and enlighten the Korean Society of Nephrology's future goals. Together with patients, healthcare providers, academic societies, and national policymakers, we need to move forward with goal-oriented drive and leadership to achieve these goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.